Positive Response and Increase in ADAMTS13 with Scheduled Rituximab in a Patient with Relapsing Thrombotic Thrombocytopenic Purpura

Thrombotic thrombocytopenic purpura (TTP) is a coagulation disorder caused by a deficiency in ADAMTS13. Patients classically present with symptoms of end-organ damage as well as anemia and thrombocytopenia. Treatment is therapeutic plasma exchange (TPE) in the acute setting, with systemic immunosupp...

Descripción completa

Detalles Bibliográficos
Autores principales: Amer, Bahaa, Patel, Anjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721890/
https://www.ncbi.nlm.nih.gov/pubmed/31516768
http://dx.doi.org/10.7759/cureus.5054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721890/
https://www.ncbi.nlm.nih.gov/pubmed/31516768
http://dx.doi.org/10.7759/cureus.5054

Ejemplares similares